What CKM syndrome means and when to ask about kidney tests

If you carry extra weight around your middle, have high blood pressure, prediabetes, type 2 diabetes, abnormal cholesterol or triglycerides, or a family history that raises kidney risk, a new U.S. guideline points to a practical question for your next primary care visit: have my kidneys been checked recently, and how do those results fit with my heart and metabolic risk?

On June 9, 2026, the American Heart Association, American College of Cardiology, American Diabetes Association, and American Society of Nephrology released the first U.S. multisociety guideline on cardiovascular-kidney-metabolic, or CKM, syndrome. Its core message is simple: blood pressure, blood sugar, blood fats, body weight, waist circumference, and kidney function should not be managed in separate silos.

What CKM syndrome means in plain language

CKM syndrome is a framework for understanding how the heart, kidneys, and metabolic health affect one another over time. In earlier stages, the pattern may begin with excess body fat, a larger waist size, insulin resistance, or prediabetes. Later stages can include high blood pressure, type 2 diabetes, chronic kidney disease, and eventually established cardiovascular disease.

That does not mean everyone with one risk factor suddenly has a new diagnosis. It means the guideline wants clinicians to connect these risks sooner, before a person develops obvious symptoms or a major heart or kidney event.

Why kidney risk gets special attention

Kidney disease is often easy to miss. CDC says more than 1 in 7 U.S. adults has chronic kidney disease, and as many as 9 in 10 do not know they have it. The agency also notes that specific blood and urine tests are needed to check for it, because many people do not feel sick early on.

NIDDK explains why that matters: diabetes and high blood pressure are two major causes shared by both kidney disease and heart disease. High blood pressure can damage the small blood vessels in the kidneys, while high blood sugar can damage the kidneys over time as well. Once kidney damage starts, it can also make blood pressure and heart risk harder to control.

What the new guideline wants checked together

The new guideline says CKM risk should be assessed as a package. In plain terms, that means reviewing:

blood pressure
blood sugar, such as fasting glucose or A1C
cholesterol and triglycerides
body weight and waist circumference
kidney function, typically with a blood test that estimates kidney filtration and a urine test that checks for excess albumin

The document also emphasizes that chronic kidney disease should be characterized with both estimated glomerular filtration rate, or eGFR, and urine albumin-to-creatinine ratio, or UACR, rather than relying on only one measure.

Why this is a broad prevention issue

This is not a niche problem limited to specialty clinics. A JAMA Network research letter using nationally representative U.S. data from 2011 through March 2020 found that stage 2 CKM was the most common stage among adults, and advanced stages were far more common in older adults. That is older prevalence data, not a live 2026 head count, but it helps explain why the new guideline treats CKM as a mainstream prevention issue.

Who should consider asking about screening now

This article is not telling every reader to request the same lab panel. But it is reasonable to ask whether your screening is up to date if you have one or more of the following:

weight carried around the abdomen or a larger waist circumference
prediabetes or type 2 diabetes
high blood pressure
abnormal cholesterol or triglycerides
known cardiovascular disease
a family history of kidney disease or kidney failure
more than one of these risks at the same time

The more these risks overlap, the more the guideline argues for a joined-up review instead of treating each issue as if it stands alone.

What is known, and what is still uncertain

What is known: this is a major clinical practice guideline that pulls together evidence across cardiology, kidney care, diabetes care, and primary care. Its practical message for patients is earlier detection and more coordinated prevention, especially for silent kidney risk.

What is still uncertain for any one person: how often testing should happen, which follow-up plan fits best, and whether CKM staging would change treatment right away. A guideline is not a diagnosis, and it does not mean every adult with a larger waist or borderline lab result needs the same testing schedule or the same medicines.

A simple next step for your next primary care visit

If this sounds relevant to you, bring three questions to your next routine visit: Have I ever had kidney screening with a blood test and a urine albumin test? How do my blood pressure, blood sugar, cholesterol, weight, and waist size fit together? How often should these be checked for me?

That keeps the conversation focused on prevention and early detection. And that is the real point of the new CKM guideline: find connected risk sooner, so there is more time to slow it down.

This article is about prevention, not diagnosis. If you have chest pain, severe shortness of breath, or feel acutely ill, seek urgent medical care rather than waiting for routine screening.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.